• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On the significance of cholecystokinin receptors in panic disorder.

作者信息

van Megen H J, den Boer J A, Westenberg H G

机构信息

Department of Psychiatry, Academic Hospital Utrecht, The Netherlands.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1235-46. doi: 10.1016/0278-5846(94)90090-6.

DOI:10.1016/0278-5846(94)90090-6
PMID:7863014
Abstract

Interest in the biological aspects of panic disorder has been focussed mainly on the noradrenergic and serotonergic systems in the brain. Recently evidence has been found that Cholecystokinin (CCK) receptors in the Central Nervous System (CNS) may be involved in panic disorders. This hypothesis is based on the results of animal electrophysiological studies, animal models of anxiety and on challenge test using CCK fragments in humans. In this review, the studies evaluating the putative involvement of CCK, and especially CCK-B receptors, in panic disorder will be discussed.

摘要

相似文献

1
On the significance of cholecystokinin receptors in panic disorder.
Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1235-46. doi: 10.1016/0278-5846(94)90090-6.
2
Cholecystokinin and panic disorder: past and future clinical research strategies.胆囊收缩素与惊恐障碍：过去及未来的临床研究策略
Scand J Clin Lab Invest Suppl. 2001;234:19-27.
3
[Is cholecystokinin a biological support in panic attacks?].[胆囊收缩素是惊恐发作的一种生物学支持因素吗？]
Encephale. 1991 Sep-Oct;17(5):475-9.
4
The cholecystokinin hypothesis of anxiety and panic disorder.
Ann N Y Acad Sci. 1994 Mar 23;713:273-82. doi: 10.1111/j.1749-6632.1994.tb44075.x.
5
Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.惊恐障碍患者的五肽胃泌素输注。I. 症状和心血管反应。
Biol Psychiatry. 1994 Jul 15;36(2):73-83. doi: 10.1016/0006-3223(94)91187-8.
6
Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.导水管周围灰质背外侧胆囊收缩素-2受体参与大鼠惊恐相关行为的调节。
Brain Res. 2005 Oct 12;1059(1):46-51. doi: 10.1016/j.brainres.2005.08.006. Epub 2005 Sep 15.
7
Vasodilatory effects of cholecystokinin: new role for an old peptide?
Regul Pept. 2006 Dec 10;137(3):179-84. doi: 10.1016/j.regpep.2006.06.006. Epub 2006 Aug 2.
8
CCK in anxiety and cognitive processes.
Neurosci Biobehav Rev. 1998 Oct;22(6):815-25. doi: 10.1016/s0149-7634(98)00011-6.
9
Neuropeptides and anxiety: focus on cholecystokinin.
Clin Chem. 1994 Feb;40(2):315-8.
10
Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.惊恐障碍的神经网络：神经肽胆囊收缩素的作用。
Depress Anxiety. 2012 Sep;29(9):762-74. doi: 10.1002/da.21919. Epub 2012 May 2.

引用本文的文献

1
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.痛觉过敏的反安慰剂效应的生化和神经内分泌基础。
J Neurosci. 2006 Nov 15;26(46):12014-22. doi: 10.1523/JNEUROSCI.2947-06.2006.
2
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
Psychopharmacology (Berl). 1997 Feb;129(3):243-8. doi: 10.1007/s002130050186.
3
Clinical uses of gut peptides.肠肽的临床应用。
Ann Surg. 1997 Feb;225(2):145-54. doi: 10.1097/00000658-199702000-00002.